Alkahest

San Carlos, United States Founded: 2014 • Age: 12 yrs Acquired By Grifols
Therapies derived from blood to treat neurological diseases.
Request Access

About Alkahest

Alkahest is a company based in San Carlos (United States) founded in 2014 was acquired by Grifols in September 2020.. Alkahest has raised $41 million across 2 funding rounds from investors including Grifols. The company has 82 employees as of December 31, 2023. Alkahest offers products and services including AKST4290, AKST/GRF6019/6021, and AKST1210.

  • Headquarter San Carlos, United States
  • Employees 82 as on 31 Dec, 2023
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Alkahest, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $41 M (USD)

    in 2 rounds

  • Latest Funding Round
    $37.5 M (USD), Series A

    Mar 04, 2015

  • Investors
  • Employee Count
    82

    as on Dec 31, 2023

  • Acquired by
    Grifols

    (Sep 07, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Alkahest

Alkahest offers a comprehensive portfolio of products and services, including AKST4290, AKST/GRF6019/6021, and AKST1210. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Drug candidate for Wet AMD and Parkinson's Disease treatment.

Targets Alzheimer's and Parkinson's with cognitive benefits.

Addresses cognitive impairment in end-stage renal disease.

People of Alkahest
Headcount 50-200
Employee Profiles 20
Board Members and Advisors 11
Employee Profiles
People
Esther Rawner
VP, Clinical Development
People
Tibor Nanasi
Senior Data Scientist
People
Chunmiao Feng
Associate Director Biostatistics, Head Of Analysis
People
Eliot Obi-Tabot M.D., Sm
Medical Director, Nephrology

Unlock access to complete

Board Members and Advisors
people
Alfredo Arroyo
Director
people
Tomás Dagá Gelabert
Director
people
David Ian Bell
Director
people
Elia Stupka
Scientific Advisor

Unlock access to complete

Funding Insights of Alkahest

Alkahest has successfully raised a total of $41M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $37.5 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $37.5M
  • First Round

    (01 Aug 2014)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2015 Amount Series A - Alkahest Valuation Grifols
Aug, 2014 Amount Seed - Alkahest Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Alkahest

Alkahest has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Grifols. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Plasma-derived therapies are developed to treat multiple diseases.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Alkahest

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Alkahest

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Alkahest Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Alkahest

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Alkahest

When was Alkahest founded?

Alkahest was founded in 2014.

Where is Alkahest located?

Alkahest is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.

Who is the current CEO of Alkahest?

Karoly Nikolich is the current CEO of Alkahest.

Is Alkahest a funded company?

Alkahest is a funded company, having raised a total of $41M across 2 funding rounds to date. The company's 1st funding round was a Seed of $3.5M, raised on Aug 01, 2014.

How many employees does Alkahest have?

As of Dec 31, 2023, the latest employee count at Alkahest is 82.

What does Alkahest do?

Alkahest is developing therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline. Its research has demonstrated that factors in blood plasma of young mice are able to reverse brain deficits in normal aging and Alzheimers disease models in mice. Clinical studies are being conducted in patients with different types of dementia and other neurodegenerative diseases. Grifols made an investment of 37.5 million for a 45 stake in Alkahest along with another 12.5 million RD and certain commercial rights.

What products or services does Alkahest offer?

Alkahest offers AKST4290, AKST/GRF6019/6021, and AKST1210.

Who are Alkahest's investors?

Alkahest has 1 investor. Key investors include Grifols.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available